Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Mar 16;19(1):114.
doi: 10.1186/s13054-015-0800-5.

Combatting resistance in intensive care: the multimodal approach of the Spanish ICU "Zero Resistance" program

José Garnacho Montero  1 , Francisco Álvarez Lerma  2 , Paula Ramírez Galleymore  3 , Mercedes Palomar Martínez  4 , Luis Álvarez Rocha  5 , Fernando Barcenilla Gaite  6 , Joaquín Álvarez Rodríguez  7 , Mercedes Catalán González  8 , Inmaculada Fernández Moreno  9 , Jesús Rodríguez Baño  10 , José Campos  11 , Jesús Ma Aranaz Andrés  12 , Yolanda Agra Varela  13 , Carolina Rodríguez Gay  14 , Miguel Sánchez García  15 ; Scientific Expert Committee for Zero Resistance Project
Collaborators, Affiliations
Review

Combatting resistance in intensive care: the multimodal approach of the Spanish ICU "Zero Resistance" program

José Garnacho Montero et al. Crit Care. .

Abstract

This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2015 and co-published as a series in Critical Care. Other articles in the series can be found online at http://ccforum.com/series/annualupdate2015. Further information about the Annual Update in Intensive Care and Emergency Medicine is available from http://www.springer.com/series/8901.

PubMed Disclaimer

References

    1. Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:1–12. doi: 10.1086/595011. - DOI - PubMed
    1. Antimicrobial resistance interactive database (EARS-Net). Available at: http://www.ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/datab... (Accessed 4 September 2014).
    1. Jones RN, Flonta M, Gurler N, Cepparulo M, Mendes RE, Castanheira M. Resistance surveillance program report for selected European nations (2011) Diagn Microbiol Infect Dis. 2014;78:429–36. doi: 10.1016/j.diagmicrobio.2013.10.008. - DOI - PubMed
    1. Cisneros JM, Rodríguez-Baño J, Fernández-Cuenca F, et al. Risk factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: A nationwide study. Clin Microbiol Infect. 2005;11:874–9. doi: 10.1111/j.1469-0691.2005.01256.x. - DOI - PubMed
    1. Villar M, Cano ME, Gato E, et al. Epidemiologic and clinical impact of Acinetobacter baumannii colonization and infection: A reappraisal. Medicine (Baltimore) 2014;93:202–10. doi: 10.1097/MD.0000000000000036. - DOI - PMC - PubMed